This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of targeted cancer therapies. It functions as a key component in the design of proteolysis-targeting chimeras (PROTACs), which are innovative molecules that degrade specific disease-causing proteins. By facilitating the ubiquitination and subsequent degradation of target proteins, it plays a crucial role in treating cancers driven by protein overexpression or mutations. Additionally, its application extends to research in neurodegenerative diseases, where it aids in studying protein aggregation and degradation pathways. Its versatility in modulating protein levels makes it a valuable tool in both therapeutic development and biochemical research.